Bacterial lipopolysaccharide (LPS), also known as endotoxin, induces profound anorexia. However, the LPS-provoked pro-inflammatory signaling cascades and the neural mechanisms underlying the development of anorexia are not clear. Mammalian target of rapamycin (mTOR) is a key regulator of metabolism, cell growth, and protein synthesis. This study aimed to determine whether the mTOR pathway is involved in LPS-induced anorexia. Effects of LPS on hypothalamic gene/protein expression in mice were measured by RT-PCR or western blotting analysis. To determine whether inhibition of mTOR signaling could attenuate LPS-induced anorexia, we administered an i.c.v. injection of rapamycin, an mTOR inhibitor, on LPS-treated male mice. In this study, we showed that LPS stimulates the mTOR signaling pathway through the enhanced phosphorylation of mTOR Ser2448 and p70S6K Thr389 . We also showed that LPS administration increased the phosphorylation of FOXO1 Ser256 , the p65 subunit of nuclear factor kappa B (P!0.05), and FOXO1/3a Thr24/32 (P!0.01). Blocking the mTOR pathway significantly attenuated the LPS-induced anorexia by decreasing the phosphorylation of p70S6K Thr389 , FOXO1 Ser256 , and FOXO1/3a Thr24/32 . These results suggest promising approaches for the prevention and treatment of LPS-induced anorexia.